Recce Pharmaceuticals Ltd RECEF
$0.22
Last Updated: Jun 24, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
RECEF Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Recce Pharmaceuticals Ltd is classified as halal.
HALAL
Report Source: undefined Quarter Report
Recce Pharmaceuticals Ltd. Stock Analysis RECEF
United States Health Care Micro Cap Recce Pharmaceuticals Ltd. is engaged in the research and development of pharmaceutical drugs that kill germs. The company is headquartered in Sydney, New South Wales. The company went IPO on 2016-01-15. The firm is engaged in the development and commercialization of a new class of synthetic anti-infectives designed to address the urgent global health problems of antibiotic-resistant superbugs and emerging viral pathogens. The firm's anti-infective pipeline includes three broad-spectrum, synthetic polymer anti-infectives: RECCE 327 as an intravenous and topical therapy that is being developed for the treatment of serious and potentially life-threatening infections due to Gram-positive and Gram-negative bacteria including their superbug forms; RECCE 435 as an orally administered therapy for bacterial infections; and RECCE 529 for viral infections. Through their multi-layered mechanisms of action, the Company's anti-infectives have the potential to overcome the processes utilized by bacteria and viruses to overcome resistance.
Recce Pharmaceuticals Ltd (RECEF) Chart
Financial Metrics & Statements of Recce Pharmaceuticals Ltd (RECEF)
FAQ's for Recce Pharmaceuticals Ltd (RECEF)
- As of August 2026, Recce Pharmaceuticals Ltd RECEF is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Recce Pharmaceuticals Ltd using these criteria to determine its compliance status.
- Muslim investors may consider investing in Recce Pharmaceuticals Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Recce Pharmaceuticals Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Recce Pharmaceuticals Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Recce Pharmaceuticals Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Related Halal Stocks to Recce Pharmaceuticals Ltd (RECEF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
